<DOC>
	<DOCNO>NCT01847365</DOCNO>
	<brief_summary>Retinitis pigmentosa ( RP ) progressive degenerative disease retina , often lead blindness . 1 4000 people UK affect RP yet establish therapy treat delay progression . Transcorneal electrical stimulation ( TES ) garner attention possible therapeutic option RP . Research show TES improve retinal cell viability visual function . An initial pilot study TES 24 participant RP demonstrate safe improve vision . This study aim confirm safety new CE-approved Okustim device characterise benefit TES large scale . 12 participant enrol 1 year across two site UK - Oxford Eye Hospital London Moorfields Eye Hospital . Recruited participant undergo weekly TES 1 eye 30 minute period 6 month . This follow 6 month observation without stimulation give total participation time 1 year . Participants assess 3 , 6 , 9 12 month initial baseline visit clinical examination , investigation questionnaire . Participants diagnosis RP capable give consent . Participants , carer , sufficient motor skill attach device . As study seek ascertain impact TES RP , participant eye disease ( e.g . diabetic retinopathy ) include study .</brief_summary>
	<brief_title>TES Treatment RP</brief_title>
	<detailed_description />
	<mesh_term>Retinitis</mesh_term>
	<mesh_term>Retinitis Pigmentosa</mesh_term>
	<criteria>Participant willing able give inform consent participation study Male Female , 18 year age Diagnosis retinitis pigmentosa ( rodcone dystrophy ) make ophthalmologist Participants visual acuity â‰¥ 0.02 ( Snellen Chart ) Able ( investigator opinion ) willing comply study requirement Willing allow General Practitioner consultant , appropriate , notified participation study Participants , designate , sufficient motor skill ( assessed investigator ) apply device independently Female participant pregnant , lactate plan pregnancy course study Diabetic Retinopathy Previous arterial venous occlusion retina Previous retinal detachment Previous silicone oil tamponade Dry exudative agerelated macular degeneration Macular oedema All form glaucoma Any form corneal degeneration reduce visual acuity Neovascularisation origin Any significant disease disorder , opinion Investigator , may either put participant risk participation study , may influence result study , participant 's ability participate study Forms mental illness relate bipolar affective schizoidaffective disorder , form dementia Simultaneous participation another interventional study history intervention effect may still persist</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Retinitis Pigmentosa</keyword>
	<keyword>Transcorneal electrical stimulation</keyword>
	<keyword>Okustim</keyword>
</DOC>